Dagco, Inc. Abb Vie Inc. Transaction History

Dagco, Inc.

$243 Million
Q3 2024

A detailed history of Dagco, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Dagco, Inc. holds 8,010 shares of ABBV stock, worth $1.41 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

8,010

Previous 8,066 0.69%

Holding current value

$1.41 Million

Previous $1.38 Million 14.32%

% of portfolio

0.65%

Previous 0.61%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $9,175 - $11,162	-56 Reduced 0.69%	8,010 $1.58 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $1,083 - $1,265	-7 Reduced 0.09%	8,066 $1.38 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.25 Million - $1.43 Million	7,847 Added 3472.12%	8,073 $1.47 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $1.13 Million - $1.27 Million	-8,214 Reduced 97.32%	226 $35,000
Q3 2023 Dec 07, 2023	BUY	$133.59 - $154.65 $935 - $1,082	7 Added 0.08%	8,440 $1.26 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $1,060 - $1,319	8 Added 0.09%	8,433 $1.14 Million
Q1 2023 May 05, 2023	BUY	$144.61 - $166.54 $1,012 - $1,165	7 Added 0.08%	8,425 $1.34 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $968 - $1,161	7 Added 0.08%	8,418 $1.36 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $12,481 - $14,315	-93 Reduced 1.09%	8,411 $1.13 Million
Q2 2022 Jul 28, 2022	BUY	$137.62 - $174.96 $825 - $1,049	6 Added 0.07%	8,504 $1.3 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $923 - $1,146	7 Added 0.08%	8,498 $1.33 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $859 - $1,087	8 Added 0.09%	8,491 $1.15 Million
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $22,982 - $26,088	-216 Reduced 2.48%	8,483 $915,000
Q2 2021 Jul 12, 2021	BUY	$105.21 - $117.21 $946 - $1,054	9 Added 0.1%	8,699 $980,000
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $1,023 - $1,126	10 Added 0.12%	8,690 $940,000
Q4 2020 Jan 28, 2021	SELL	$80.49 - $108.67 $3,300 - $4,455	-41 Reduced 0.47%	8,680 $930,000
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $773 - $907	9 Added 0.1%	8,721 $764,000
Q2 2020 Jul 27, 2020	SELL	$73.37 - $98.18 $28,614 - $38,290	-390 Reduced 4.28%	8,712 $855,000
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $645 - $977	10 Added 0.11%	9,102 $693,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $11,973 - $14,981	-166 Reduced 1.79%	9,092 $805,000
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $437,270 - $525,723	-6,943 Reduced 42.86%	9,258 $701,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $30,550 - $39,050	-465 Reduced 2.79%	16,201 $1.18 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $45,589 - $53,656	-591 Reduced 3.42%	16,666 $1.34 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $1.34 Million - $1.66 Million	17,257 New	17,257 $1.59 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.

Account